201 related articles for article (PubMed ID: 16616827)
1. Systemic chemotherapy in the management of malignant peritoneal mesothelioma.
Garcia-Carbonero R; Paz-Ares L
Eur J Surg Oncol; 2006 Aug; 32(6):676-81. PubMed ID: 16616827
[TBL] [Abstract][Full Text] [Related]
2. Gemcitabine and vinorelbine as second-line or beyond treatment in patients with malignant pleural mesothelioma pretreated with platinum plus pemetrexed chemotherapy.
Toyokawa G; Takenoyama M; Hirai F; Toyozawa R; Inamasu E; Kojo M; Morodomi Y; Shiraishi Y; Takenaka T; Yamaguchi M; Shimokawa M; Seto T; Ichinose Y
Int J Clin Oncol; 2014 Aug; 19(4):601-6. PubMed ID: 24158772
[TBL] [Abstract][Full Text] [Related]
3. Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.
de Perrot M; Feld R; Cho BC; Bezjak A; Anraku M; Burkes R; Roberts H; Tsao MS; Leighl N; Keshavjee S; Johnston MR
J Clin Oncol; 2009 Mar; 27(9):1413-8. PubMed ID: 19224855
[TBL] [Abstract][Full Text] [Related]
4. Gemcitabine and vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma.
Zucali PA; Ceresoli GL; Garassino I; De Vincenzo F; Cavina R; Campagnoli E; Cappuzzo F; Salamina S; Soto Parra HJ; Santoro A
Cancer; 2008 Apr; 112(7):1555-61. PubMed ID: 18286536
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy options and new advances in malignant pleural mesothelioma.
Steele JP; Klabatsa A
Ann Oncol; 2005 Mar; 16(3):345-51. PubMed ID: 15677623
[TBL] [Abstract][Full Text] [Related]
6. The emerging role of antifolates in the treatment of malignant pleural mesothelioma.
Fizazi K; John WJ; Vogelzang NJ
Semin Oncol; 2002 Feb; 29(1):77-81. PubMed ID: 11836672
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of the frontline platinum-based combination chemotherapy in malignant peritoneal mesothelioma.
Kim ST; Park JY; Lee J; Park JO; Park YS; Lim HY; Kang WK; Park SH
Jpn J Clin Oncol; 2010 Nov; 40(11):1031-6. PubMed ID: 20534685
[TBL] [Abstract][Full Text] [Related]
8. Emerging insights into the biology and therapy of malignant mesothelioma.
Vogelzang NJ
Semin Oncol; 2002 Dec; 29(6 Suppl 18):35-42. PubMed ID: 12571809
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy and targeted therapies for unresectable malignant mesothelioma.
Kelly RJ; Sharon E; Hassan R
Lung Cancer; 2011 Sep; 73(3):256-63. PubMed ID: 21620512
[TBL] [Abstract][Full Text] [Related]
10. Successful salvage chemotherapy with gemcitabine and vinorelbine in a malignant pleural mesothelioma patient previously treated with pemetrexed.
Agatsuma T; Koizumi T; Yasuo M; Urushihata K; Tsushima K; Yamamoto H; Hanaoka M; Fukushima M; Honda T; Kubo K
Jpn J Clin Oncol; 2010 Dec; 40(12):1180-3. PubMed ID: 20603247
[TBL] [Abstract][Full Text] [Related]
11. Raltitrexed plus cisplatin is cost-effective compared with pemetrexed plus cisplatin in patients with malignant pleural mesothelioma.
Woods B; Paracha N; Scott DA; Thatcher N
Lung Cancer; 2012 Feb; 75(2):261-7. PubMed ID: 21937141
[TBL] [Abstract][Full Text] [Related]
12. [Malignant pleural mesothelioma].
Nishiwaki Y
Gan To Kagaku Ryoho; 2003 May; 30(5):589-94. PubMed ID: 12795087
[TBL] [Abstract][Full Text] [Related]
13. Malignant peritoneal mesothelioma in a child: chemotherapy with gemcitabine and platinum was effective for the disease unresponsive to other treatments.
Kobayashi S; Waragai T; Sano H; Mochizuki K; Akaihata M; Ohara Y; Hosoya M; Kikuta A
Anticancer Drugs; 2014 Oct; 25(9):1102-5. PubMed ID: 25010395
[TBL] [Abstract][Full Text] [Related]
14. Novel combinations using pemetrexed in malignant mesothelioma.
Gadgeel SM; Pass HI
Clin Lung Cancer; 2004 Apr; 5 Suppl 2():S61-6. PubMed ID: 15117427
[TBL] [Abstract][Full Text] [Related]
15. The use of chemotherapy in patients with advanced malignant pleural mesothelioma: a systematic review and practice guideline.
Ellis P; Davies AM; Evans WK; Haynes AE; Lloyd NS;
J Thorac Oncol; 2006 Jul; 1(6):591-601. PubMed ID: 17409924
[TBL] [Abstract][Full Text] [Related]
16. Systemic chemotherapy with pemetrexed and cisplatin for malignant peritoneal mesothelioma: a single institution experience.
Lainakis G; Zagouri F; Kastritis E; Sergentanis TN; Bozas G; Dimopoulos MA; Papadimitriou CA
Tumori; 2011; 97(1):25-9. PubMed ID: 21528659
[TBL] [Abstract][Full Text] [Related]
17. An unusually large pleural mesothelioma with an outstanding clinical response and long lasting survival: a case report and literature review.
Zilembo N; Vitali M; Pietrantonio F; Platania M; Del Vecchio M; Bajetta E
Tumori; 2010; 96(6):1031-4. PubMed ID: 21388071
[TBL] [Abstract][Full Text] [Related]
18. Comparison of cisplatin plus pemetrexed and cisplatin plus gemcitabine for the treatment of malignant pleural mesothelioma in Japanese patients.
Shukuya T; Takahashi T; Imai H; Tokito T; Ono A; Akamatsu H; Taira T; Kenmotsu H; Naito T; Murakami H; Endo M; Yamamoto N
Respir Investig; 2014 Mar; 52(2):101-6. PubMed ID: 24636265
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin and gemcitabine in malignant mesothelioma.
Nowak AK; Byrne MJ
Ann Oncol; 2005 Oct; 16(10):1711. PubMed ID: 16000339
[No Abstract] [Full Text] [Related]
20. Pemetrexed disodium in combination with cisplatin versus other cytotoxic agents or supportive care for the treatment of malignant pleural mesothelioma.
Green J; Dundar Y; Dodd S; Dickson R; Walley T
Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD005574. PubMed ID: 17253564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
